HBV-IN-52 is a selective HBV inhibitor. HBV-IN-52 is a Neplanocin A (HY-130430) derivative that demonstrates significant activity against HBV replication with EC50 = 0.96 µM. HBV-IN-52 can inhibit HBsAg secretion (EC50 = 0.82 µM. HBV-IN-52 can be studied in research for chronic hepatitis B (CHB) infections[1].
Molecular Weight:
388.16
Formula:
C12H13IN4O3
Target:
HBV
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
